Shares of China Medical System Holdings Limited (OTCMKTS:CHSYF – Get Rating) shot up 3.9% during mid-day trading on Friday . The stock traded as high as $1.60 and last traded at $1.60. 1,991 shares were traded during mid-day trading, a decline of 20% from the average session volume of 2,475 shares. The stock had previously closed at $1.54.
China Medical System Stock Up 3.9 %
The stock’s fifty day moving average is $1.42 and its 200-day moving average is $1.42.
China Medical System Company Profile
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.
See Also
- Get a free copy of the StockNews.com research report on China Medical System (CHSYF)
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
- FedEx Takes Flight; Analysts See More Gains Ahead
Receive News & Ratings for China Medical System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Medical System and related companies with MarketBeat.com's FREE daily email newsletter.
